整形外科用成長因子の世界市場：規模、シェア、動向分析（2025年～2031年）：MedCore

世界の整形外科用成長因子の市場規模は、2024年に10億5,000万米ドルとなりました。同市場は、2.2％のCAGRで拡大し、2031年には12億米ドルに達すると予測されています。

COVID-19の大流行により、2020年には選択手術のキャンセルによる売上減少が発生しました。この一時的な混乱にもかかわらず、市場は2022年までに力強く回復し、安定した成長に戻っています。

脊椎固定術は依然として整形外科用成長因子の成長の重要な原動力です。現在進行中の臨床研究が、骨癒合と脊椎治療における成長因子の有効性を裏付けています。企業は適応拡大についてFDAの承認を得ており、整形外科用成長因子の幅広い採用につながっています。最近の承認は、頸椎椎間板変性症および後肢／足関節固定術分野の成長に拍車をかけています。

当レポートでは、世界の整形外科用成長因子市場について調査し、市場の概要とともに、市場分析と予測、促進要因と抑制要因、競合情勢などを提供しています。

目次

エグゼクティブサマリー

• 世界の整形外科用成長因子市場概要
• 競合分析
• 市場セグメンテーション
• 対象地域

イントロダクション

手技件数

市場分析と予測

件数分析

• 頸椎椎間板変性成長因子
• 脛骨骨折整形外科用成長因子
• 脊椎整形外科成長因子
• 足首と後足部融合成長因子

促進要因と抑制要因

競合市場シェア分析

LIST OF CHARTS

• Chart 5-1: Orthopedic Growth Factor Market, Global, 2024 & 2031
• Chart 5-2: Orthopedic Growth Factor Procedures, Global, 2024
• Chart 5-3: Orthopedic Growth Factor Procedures by Segment, Global, 2021 - 2031
• Chart 5-4: Orthopedic Growth Factor Device Market, Global, 2021 - 2031
• Chart 5-5: Leading Competitors, Orthopedic Growth Factor Market, Global, 2024

LIST OF FIGURES

• Figure 5-1: Orthopedic Growth Factor Procedure Segmentation
• Figure 5-2: Orthopedic Growth Factor Market Segmentation
• Figure 5-3: Orthopedic Growth Factor Regions Covered, Global (1 of 2)
• Figure 5-4: Orthopedic Growth Factor Regions Covered, Global (2 of 2)
• Figure 5-5: Orthopedic Growth Factor Procedures by Region, Global, 2024 - 2031
• Figure 5-6: Orthopedic Growth Factor Procedures by Country, North America, 2021 - 2031
• Figure 5-7: Orthopedic Growth Factor Procedures by Country, Latin America, 2021 - 2031 (1 of 2)
• Figure 5-8: Orthopedic Growth Factor Procedures by Country, Latin America, 2021 - 2031 (2 of 2)
• Figure 5-9: Orthopedic Growth Factor Procedures by Country, Western Europe, 2021 - 2031
• Figure 5-10: Orthopedic Growth Factor Procedures by Country, Central & Eastern Europe, 2021 - 2031 (1 of 2)
• Figure 5-11: Orthopedic Growth Factor Procedures by Country, Central & Eastern Europe, 2021 - 2031 (2 of 2)
• Figure 5-12: Orthopedic Growth Factor Procedures by Country, Middle East, 2021 - 2031
• Figure 5-13: Orthopedic Growth Factor Procedures by Country, Asia-Pacific, 2021 - 2031 (1 of 3)
• Figure 5-14: Orthopedic Growth Factor Procedures by Country, Asia-Pacific, 2021 - 2031 (2 of 3)
• Figure 5-15: Orthopedic Growth Factor Procedures by Country, Asia-Pacific, 2021 - 2031 (3 of 3)
• Figure 5-16: Orthopedic Growth Factor Procedures by Country, Africa, 2021 - 2031
• Figure 5-17: Orthopedic Growth Factor Market, Global, 2021 - 2031
• Figure 5-18: Units Sold by Region, Orthopedic Growth Factor Market, Global, 2021 - 2031
• Figure 5-19: Average Selling Price by Region, Orthopedic Growth Factor Market, Global, 2021 - 2031 (US$)
• Figure 5-20: Market Value by Region, Orthopedic Growth Factor Market, Global, 2021 - 2031 (US$M)
• Figure 5-21: Cervical Disc Degeneration Growth Factor Units Sold by Region, Global, 2021 - 2031
• Figure 5-22: Tibial Fracture Growth Factor Units Sold by Region, Global, 2021 - 2031
• Figure 5-23: Spine Growth Factor Units Sold by Region, Global, 2021 - 2031
• Figure 5-24: Ankle & Hindfoot Fusion Growth Factor Units Sold by Region, Global, 2021 - 2031
• Figure 5-25: Leading Competitors, Orthopedic Growth Factor Market, Global, 2024

The global orthopedic growth factor market was valued at $1.05 billion in 2024 and is projected to grow at a CAGR of 2.2%, reaching $1.2 billion by 2031.

This market is segmented by indication type, including:

• Cervical Disc Degeneration
• Tibial Fractures
• Spine
• Ankle & Hindfoot Fusion

Market Insights & Data Coverage

• Unit Sales & Average Selling Prices
• Market Size & Growth Trends
• Procedure Numbers
• Market Drivers & Limiters
• Market Forecasts Until 2031
• Historical Data (2021-2023)
• Competitive Landscape, Mergers & Acquisitions
• Company Profiles & Product Portfolios

Market Trends

• Impact of COVID-19 on Market Growth:

* The COVID-19 pandemic led to a decline in sales due to canceled elective surgeries in 2020.

* Despite this temporary disruption, the market recovered strongly by 2022 and returned to steady growth.

• Continued Demand for Spinal Fusion Therapies:

* Spinal fusion remains a key driver of growth for orthopedic growth factors.

* Ongoing clinical research supports the efficacy of growth factors in bone healing and spinal procedures.

• Regulatory Approvals Expanding Market Reach:

* Companies are securing FDA approvals for expanded indications, leading to wider adoption of orthopedic growth factors.

* Recent approvals have fueled growth in the cervical disc degeneration and hindfoot/ankle fusion segments.

Market Share Insights

Top Competitors in the Global Orthopedic Growth Factor Market (2024):

1 Medtronic

* Market leader in the orthopedic growth factor segment.

* INFUSE(R) remains the gold standard for spinal fusion therapies.

2 Cerapedics

* Second-largest market share with its i-Factor(TM) product.

* Expanded FDA approval allows i-Factor(TM) to be used in single-level anterior cervical discectomy fusion (ACDF) with an allograft bone ring or fusion interbody device.

3 Stryker

* Third-largest competitor, known for its AUGMENT(R) product line.

* AUGMENT(R) is the first and only FDA-approved alternative to autograft for hindfoot and ankle arthrodesis.

Market Segmentation Summary

Cervical Disc Degeneration Market

• Growth factors aiding in cervical spine fusion procedures.

Tibial Fracture Market

• Orthopedic growth factors used in tibial fracture repair and bone healing.

Spine Market

• Key segment driven by spinal fusion procedures.

Ankle & Hindfoot Fusion Market

• Focus on bone regeneration and fusion techniques for foot and ankle disorders.

Global Research Scope

• Regions Covered:

* North America (U.S., Canada)

* Latin America (Brazil, Mexico, Argentina, Colombia, Chile)

* Western Europe (Germany, France, U.K., Spain, Italy)

* Central & Eastern Europe (Poland, Russia, Turkey, Hungary)

* Middle East (Saudi Arabia, UAE, Israel)

* Asia Pacific (China, Japan, India, South Korea, Australia)

* Africa (South Africa, Egypt, Nigeria, Kenya)

• Base Year: 2024
• Forecast Period: 2025-2031
• Historical Data: 2021-2023

Quantitative Coverage

• Market Size, Market Shares
• Market Forecasts, Growth Rates
• Units Sold, Average Selling Prices
• Procedure Numbers

Qualitative Coverage

• COVID-19 Impact
• Market Growth Trends & Limiters
• Competitive Analysis & SWOT for Top Competitors
• Mergers & Acquisitions
• Company Profiles & Product Portfolios
• FDA Recalls, Disruptive Technologies
• Disease Overviews

Data Sources:

• Primary Interviews with Industry Leaders
• Government Physician Data & Regulatory Data
• Hospital Private Data
• Import & Export Data
• iData Research Internal Database

TABLE OF CONTENT

• 5.1 Executive Summary
  • 5.1.1 Global Orthopedic Growth Factor Market Overview
  • 5.1.2 Competitive Analysis
  • 5.1.3 Procedure Segmentation
  • 5.1.4 Market Segmentation
  • 5.1.5 Regions Included
• 5.2 Introduction
• 5.3 Procedure Numbers
• 5.4 Market Analysis and Forecast
• 5.5 Unit Analysis
  • 5.5.1 Cervical Disc Degeneration Growth Factor Units Sold
  • 5.5.1 Tibial Fracture Orthopedic Growth Factor Units Sold
  • 5.5.2 Spine Orthopedic Growth Factor Units Sold
  • 5.5.3 Ankle & Hindfoot Fusion Growth Factor Units Sold
• 5.6 Drivers and Limiters
  • 5.6.1 Market Drivers
  • 5.6.2 Market Limiters
• 5.7 Competitive Market Share Analysis